Schmieg Resigns as CFO of Sirna; Venuti Moves from Celera to Discovery Partners; Evans to be CEO of OGT; Brenner Wins Life Science Achievement Award; and others | GenomeWeb

Martin Schmieg has resigned as senior vice president and CFO of Sirna Therapeutics for personal and family reasons, effective April 22, the Boulder, Colo-based said last week. He will continue to help the company during a transition period after hiring a new CFO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.